1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition

Linsen Li, Antony A. Okumu, Sheri Nolan, Anthony E. English, Sandip Vibhute, Yanran Lu, Katherine Hervert-Thomas, Justin T. Seffernick, Lovette Azap, Serena L. Cole,

ACS Infectious Diseases · 2019 · 34 citations · 42 references

Concepts

Abstract

(MRSA) is needed to counteract the significant threat that MRSA presents to human health. Novel inhibitors of DNA gyrase and topoisomerase IV (TopoIV) constitute one highly promising approach, but continued optimization is required to realize the full potential of this class of antibiotics. Herein, we report further studies on a series of dioxane-linked derivatives, demonstrating improved antistaphylococcal activity and reduced hERG inhibition. A subseries of analogues also possesses enhanced inhibition of the secondary target, TopoIV.

References

42